Holen Sie sich die Stockscreener-App
8.48
5.33%
0.50
Schlusskurs vom Vortag:
$7.98
Offen:
$8.03
24-Stunden-Volumen:
1.07M
Relative Volume:
0.52
Marktkapitalisierung:
$1.03B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-29.24
EPS:
-0.29
Netto-Cashflow:
$-31.85M
1W Leistung:
-13.79%
1M Leistung:
+12.82%
6M Leistung:
+28.12%
1J Leistung:
+146.48%
1-Tages-Spanne:
$8.03
$8.49
1-Wochen-Bereich:
$7.645
$9.70
52-Wochen-Spanne:
$2.36
$9.92
Trevi Therapeutics Inc Stock (TRVI) Company Profile
Firmenname
Trevi Therapeutics Inc
Sektor
Branche
Telefon
203-304-2499
Adresse
195 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie TRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
8.475 | 971.78M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.44 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.04 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.42 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.63 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.17 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-05-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-10 | Bestätigt | Needham | Buy |
| 2025-03-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-30 | Eingeleitet | Raymond James | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-12 | Eingeleitet | B. Riley Securities | Buy |
| 2022-11-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-06-03 | Eingeleitet | Needham | Buy |
| 2019-06-03 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Trevi Therapeutics Inc Aktie (TRVI) Neueste Nachrichten
Trevi Therapeutics to present two phase 2a River trial posters at ERS Congress 2025 - MarketScreener
Clinical Trial Results: Trevi's Breakthrough Chronic Cough Treatment Data to be Featured at European Congress - Stock Titan
Will Trevi Therapeutics Inc outperform its industry peers2025 Trading Recap & Long-Term Capital Growth Strategies - خودرو بانک
Trevi Therapeutics (NASDAQ:TRVI) Shares Down 4.6%Here's What Happened - MarketBeat
Woodline Partners LP Sells 1,154,785 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Siren L.L.C. Trims Holdings in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Trevi Therapeutics (NASDAQ:TRVI) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Fred Alger Management LLC Invests $482,000 in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Gap Down: What is the PEG ratio of Trevi Therapeutics IncJuly 2025 Movers & AI Powered Trade Plan Recommendations - خودرو بانک
Dividend Watch: How much upside does Sintx Technologies Inc. haveMarket Rally & Risk Controlled Stock Pick Alerts - خودرو بانک
Revenue Check: How does Trevi Therapeutics Inc compare to its peersJuly 2025 Review & Risk Managed Investment Entry Signals - خودرو بانک
Risk Analysis: Will MSAI face regulatory challengesJuly 2025 Spike Watch & AI Driven Price Forecasts - خودرو بانک
Aug Volume: How does Trevi Therapeutics Inc compare to its peersQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - خودرو بانک
Aug Wrap: Can Trevi Therapeutics Inc continue delivering strong returnsJuly 2025 Short Interest & Reliable Trade Execution Plans - خودرو بانک
Fund Flows: Will AVTX benefit from geopolitical trendsWeekly Trade Analysis & Breakout Confirmation Trade Signals - خودرو بانک
Trade Recap: Can Trevi Therapeutics Inc continue delivering strong returnsWeekly Stock Summary & Pattern Based Trade Signal System - خودرو بانک
US Market Wrap: Can Trevi Therapeutics Inc. keep up with sector leadersWeekly Trade Review & Daily Volume Surge Signals - خودرو بانک
Aug PreEarnings: Will Trevi Therapeutics Inc outperform its industry peersMarket Performance Summary & Entry Point Strategy Guides - خودرو بانک
Trevi Therapeutics (NASDAQ:TRVI) Hits New 1-Year HighTime to Buy? - MarketBeat
Acorn Capital Advisors LLC Has $13.49 Million Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Octagon Capital Advisors LP Acquires Shares of 3,322,000 Trevi Therapeutics, Inc. $TRVI - MarketBeat
163,738 Shares in Trevi Therapeutics, Inc. $TRVI Purchased by Exome Asset Management LLC - MarketBeat
Brokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) PT at $21.75 - MarketBeat
Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley - MSN
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Up 8.9%Should You Buy? - MarketBeat
Trevi Therapeutics, Inc. $TRVI Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Polar Asset Management Partners Inc. Purchases New Shares in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Raymond James Financial Inc. Has $3.20 Million Stock Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Cubist Systematic Strategies LLC Acquires 117,653 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Trevi Therapeutics stock hits 52-week high at $8.80 - Investing.com
Trevi Therapeutics stock hits 52-week high at $8.80 By Investing.com - Investing.com Nigeria
Trevi Therapeutics at Morgan Stanley Conference: Strategic Focus on Cough Treatments - Investing.com Canada
Is Trevi Therapeutics Inc. stock poised for growthWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
15 Best Multibagger Stocks to Invest in Right Now - Insider Monkey
Retail Trends: Is Trevi Therapeutics Inc. stock technically oversoldBull Run & Consistent Return Investment Signals - Lancaster City Council
What the charts say about Trevi Therapeutics Inc. today2025 Retail Activity & Technical Buy Zone Confirmations - Newser
What Fibonacci levels say about Trevi Therapeutics Inc. rebound2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profile2025 Volatility Report & Weekly Top Gainers Trade List - Newser
Trevi Therapeutics Inc. stock daily chart insightsPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmapsMarket Activity Summary & Fast Moving Market Watchlists - Newser
Heatmap analysis for Trevi Therapeutics Inc. and competitors2025 Valuation Update & Weekly High Return Opportunities - Newser
Panagora Asset Management Inc. Purchases 219,600 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Market reaction to Trevi Therapeutics Inc.’s recent newsJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser
Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Trevi Therapeutics Inc-Aktie (TRVI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
0.07%
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):